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Fig 1. Sodium dodecylsulfate-polyacrylamide gel elec-
trophoresis of "old" and "new" preparations of Sigma E-
1250 type I porcine pancreatic elastase, run under nonde-
naturing conditions and stained for total protein (2 ~L per
lane). Elastase is expected to migrate at approximately 30
kD (*). Several of the proteins removed during the
"enhanced" preparation of E-1250 are indicated by
arrows. Although the "old" preparation is effective in the
induction of experimental abdominal aortic aneurysms,
the "new" preparation is not.
Mr, Molecular weight markers; AAA, abdominal aortic
aneurysms.
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Regarding "Impact of a critical pathway on
postoperative length of stay and outcomes after
infrainguinal bypass"
To the Editors:
The article by Stanley et al (J Vasc Surg 1998;27:1056-
65) on the impact of a critical pathway on postoperative
length of stay and outcomes after infrainguinal bypass
grafting involves a carefully and thoroughly worked out
analysis that should set a standard for future investigators.
The authors have attempted to define those factors
that lead to increased hospital stay. In addition, any unto-
ward events that are caused by early discharge are ana-
lyzed. One variable not considered is the impact of open
versus semi-closed bypass grafting techniques. Myexperi-
ence in 16 years of performing in situ surgery has been
that there is a marked reduction in length of stay with the
semi-closed technique regardless of other variables. This
notion is on the basis of simple observation and must be
verified or nullified by more scientific studies.
My major concern, which was covered to some extent
in this article, is the possible deleterious effect of prema-
"Variable induction of experimental abdominal aortic
aneurysms with different preparations of porcine
pancreatic elastase"
To the Editors:
Many experimental studies on the pathogenesis of
abdominal aortic aneurysms have used the e1astase-
induced rodent model first described in 1990 by Anidjar
et al. l We wish to make the readership aware of an impor-
tant, recently recognized problem with this model that is
not apparent from the published literature.
Nearly every report that uses the Anidjar model describes
the use of type I porcine pancreatic elastase purchased from
Sigma Chemical Company (catalog no. E-1250, St Louis,
Mo). In February 1997, Sigma introduced a new assay sys-
tem to measure the elastase activity of these preparations.
Despite considerable experience with the Anidjar model and
the use ofa conversion factor to calculate the amount ofelas-
tase activity necessitated, we subsequently found that aortic
perfusion with E-1250 elastase no longer induced the
process of aneurysmal degeneration. We later learned that
the company also had introduced a modification in the
purification ofpancreatic elastase that results in a preparation
with fewer contaminating proteases (Harry Dapron, Sigma
Chemical Company, personal communication). Indeed, our
own studies also revealed a considerable difference between
the "old" and "new" preparations ofE-1250 elastase by pro-
tein gel electrophoresis (Fig 1). These findings led us to the
conclusion that one or more of the substances removed dur-
ing the additional "enhancement" is actually necessary for
the induction of experimental aneurysms.
Although the old formulation of E-1250 is no longer
available for purchase, Sigma has generously provided us
with the remaining lots of the previous E-1250 elastase.
This preparation continues to be effective for the induc-
tion of aneurysms in the rat, and we are presently attempt-
ing to identify the critical substances that were removed
during the additional purification of pancreatic elastase.
Nonetheless, we are aware of at least three other laborato-
ries that have been unable to establish or reproduce the
Anidjar model during the past year with the commercially
available E-1250 elastase preparation. Therefore, it is
important that other investigators be made aware of this
problem before planning studies with the elastase-induced
model of aortic aneurysm in rats.
John A. Curci, MD
Robert W Thompson, MD
Washington University School of Medicine
St Louis, Mo
24/41/94659
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ture discharge. Cost-driven criteria for keeping a patient in
the hospital risk a minefield of potential difficulties and
dangers. The earlier the discharge, the less daily observa-
tions the responsible surgeon can make. Next will come
pathways that suggest that the primary physicians can
manage the postoperative care except under certain con-
ditions that requiring reevaluation by the surgeon.
Indeed, the authors imply a loss of observation after dis-
charge to an intermediate facility: "Because we were
unable to obtain information regarding intermediate-care
after discharge from our service, it is impossible for us to
comment about the effect of the critical pathway on over-
all hospitalization."
This article ought to be read and scrutinized by every
vascular surgeon. I would hope to see more articles like
this one that balance the cost effectiveness of critical path-
ways against the possible adverse consequences. We must,
in the final analysis, cooperate with the cost savers but not
comply in a Faustian sense.
If critical pathways and care maps become simple
housekeeping, laundry lists to be conveniently checked off
by physicians and other caregivers, they serve useful func-
tions. My fear is that they will become reflections of a pre-
vailing orthodoxy, behind and through which third-party
payers continue to ration health care always behind the
mask of "quality." Most of us have become quite aware of
that pathway!
This said, I commend Dr Stanley and his group for a
thoughtful and exhaustive paper outlining many of the
factors that surgeons must consider in developing effec-
tive, safe, and quality-conscious critical pathways.
George D. LeMaitre
Vascular and General Surgery
Tufts Universiry School of Medicine
Andover, MD
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Regarding "A comparison of carotid angioplasty with
stenting versus endarterectomy with regional
anesthesia"
To the Editors:
We were interested to read the recent report in the
Journal of Vascular Surgery by William D. Jordan, Jr, et al
(J Vase Surg 1998;28:397-403) of the comparison of
carotid endarterectomy (CEA) with percutaneous translu-
minal angioplasty with stenting (PTAS). However, we take
issue with their conclusion that PTAS carries a significantly
higher neurologic risk and that no further clinical investiga-
tion is needed. No comparison and no statistics can be per-
formed in the absence ofprospective randomization, and so
there can be no "significantly" higher risk. We would agree
that PTAS is not at present an acceptable alternative to
CEA, but similarly, PTAS cannot be reserved for "specific
situations in which surgical treatment is not appropriate"
because we have no idea what the indications are.
Since 1996, our group has performed 52 PTAS pro-
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cedures in 48 patients, but we have had more complica-
tions than has the Birmingham group. Our stroke and
death rate was 22% in patients who were asymptomatic (4
ofl8 patients) and 18% in patients who were symptomatic
(6 of 34 patients). Therefore, we no longer perform PTAS
on patients who are asymptomatic. Nearly all the patients
who were symptomatic were rejected for surgery, as in the
Alabama series. They had severe symptomatic ulcerated
carotid lesions with critical stenosis that carried an annual
stroke risk of 18% and at the same time had systemic com-
plications that made CEA foolhardy. We believed that it
was justified in these cases to advise the procedure when
we had fully explained to the patient the high risks of the
procedure versus the high risks of conservative therapy.
Most patients preferred to risk death rather than survive a
severe stroke.
However, there are some practical caveats. First, with
the stroke and death risk of patients who were asympto-
matic at only 2% to 3% per year, PTAS cannot be justified
in this group unless the investigators can guarantee a com-
bined risk of angiosurgery of less than 2.3%, as in the
Asymptomatic Carotid Atherosclerosis Study.1 In a recent
Canadian consensus of neurologists, even this rate was
believed to be unjustifiably risky.2
Second, we are concerned that many PTAS procedures
are being performed by operators with no reference to
clinical neurologists, neurosurgeons, or vascular surgeons,
and to whom everything above the clavicles is "terra
incognita."
Deplore as we may the wide use of PTAS, the truth is
that it is escalating in popularity, mainly as a result of its
noninvasive technique. It is precisely for this reason that
the procedure should be evaluated on a scientific footing.
We cannot believe the Alabama group is serious when they
state that they do not support a randomized trial of the
two procedures until "techniques are further modified."
All strategies in medical management, whether medical or
surgical, are continually evolving. As Dr Clagett points out
in the discussion with Dr Jordan, only a single, properly
performed trial of 659 patients was needed to establish an
evidence-based justification for CEA3 in patients who
were symptomatic after evaluations of tens of thousands of
patients for CEA were repeatedly inconclusive. We need a
randomized study, and urgently!
John W. Norris, MD, FRCP
Beverley Bowyer, RN
Liliana Smurawska, MD
Robert Maggisano, MD, FRCSC
Vascular Research Unit
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
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